BDBM255774 (3aR,5R,6S,7S,7aR)-5- (hydroxymethyl)-2-(methylamino)- 5,6,7,7a-tetrahydro-3aH-pyrano[3,2- d]thiazole-6,7-diol::US9701693, 4
SMILES: CNC1=N[C@H]2[C@H](O[C@H](CO)[C@@H](O)[C@H]2O)S1
InChI Key: InChIKey=RPZPRSQYGSVMTF-BNWJMWRWSA-N
Data: 1 KI
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM255774 ((3aR,5R,6S,7S,7aR)-5- (hydroxymethyl)-2-(methylami...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 0.700 | -12.5 | n/a | n/a | n/a | n/a | n/a | n/a | 25 |
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp. US Patent | Assay Description A variety of tissue culture cell lines, expressing endogenous levels of O-GlcNAcase, can be utilized; examples include rat PC-12, and human U-87, or ... | US Patent US9701693 (2017) BindingDB Entry DOI: 10.7270/Q21J9CT5 | |||||||||||
More data for this Ligand-Target Pair |